But i am sure these figures will be conservative. In fact each time the results will come out after each quarter, people will multiply this by 4 to annualise and I am pretty sure we will see for Q4 a pps of 4x$0.57=2.28x 25(P/E ratio)= $57.00
But I prefer to be very conservative and say less. In 2 years we will have over $150.00/share...if there is no takeover.
I have to admit that hiring 35 salesperson and train them correctly on ACHTAR in a very short period of time is very difficult and not rewarding in 1-2 months.
After my post I have seen I have been too excessive. Mr. Don Baily, CEO of QCOR, is on the right track. His moto of saying " SELL ACHTAR" is the right one. We do not even need another product in the pipeline because ACTHAR is so a special drug and it is so good for the people that QCOR will make a fortune with this product while helping a lot of people. (I know there are others BTW). ACTHAR is THE product of the century.